|
AAP News Vol. 30 No. 11 November 2009, p. 11 © 2009 American Academy of Pediatrics
Breastfeeding advice for mothers with possible H1N1 infectionRuth A. Lawrence, M.D., FAAP and John S. Bradley, M.D., FAAP
Neonates and infants younger than 6 months of age are at risk for complications from seasonal influenza and presumably 2009 H1N1 influenza (swine flu), although the morbidity and mortality from this new virus have not yet been described. While the advantages of breastfeeding are well-known, this close interaction of mother and newborn also can facilitate transmission of influenza virus. The benefits and the risks of close contact must be considered carefully.
These precautions are designed to minimize the risk of transmission until mothers immune response to H1N1 influenza is established, and increased, specific immune protection may be provided by breast milk. Note that influenza virus does not pass through breast milk.
For any mother with H1N1 influenza infection who presents in labor to a health care institution, testing and empirically starting therapy for influenza with an antiviral is suggested. Oseltamivir (Tamiflu) or zanamivir (Relenza) will hasten resolution of symptoms and infectivity, particularly if treatment is started within 48 hours of onset of illness. Neonatal exposure to oseltamivir (Tamiflu) excreted in breast milk is extremely low. Immediately following delivery, the precautions listed previously should be instituted as the newborn infant is first placed into mothers arms. These precautions should be followed until mothers illness is resolved, i.e., no fever, as measured without antipyretics, for 24 hours. While no data exist to support these suggestions, it is believed that these represent an appropriate balance between the benefits of mother-infant interaction and the risks of serious neonatal infection. Institutions may wish to modify these suggestions to address their needs and medical practices. Dr. Lawrence is chair of the AAP Section on Breastfeeding executive committee. Dr. Bradley is a member of the AAP Committee on Infectious Diseases.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||